The intracellular activation of lamivudine (3TC) and determination of 2′-deoxycytidine-5′-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells-Reference-Cited by-同舟云学术

The intracellular activation of lamivudine (3TC) and determination of 2′-deoxycytidine-5′-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells

Published:2000-12 Issue:6 Volume:50 Page:597-604
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Kewn Stephen,Hoggard Patrick G.,Sales D.,Johnson A.,Back David J., ,

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2000.00302.x/fullpdf

Reference43 articles.

1. Hepatocellular carcinoma and hepatitis B virus;Beasley;Lancet,1981

2. Survival in chronic hepatitis B. an analysis of 379 patients;Weissberg;Ann Intern Med,1984

3. The molecular biology of the hepatitis B viruses;Ganem;Annu Rev Biochem,1987

4. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis;Wang;Cell,1992

5. Interferon in viral hepatitis: role in pathogenesis and treatment;Davis;Hepatology,1986

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs;European Journal of Medicinal Chemistry;2022-04

2. CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target;SLAS DISCOVERY: Advancing the Science of Drug Discovery;2020-11-18

3. CETSA® MS profiling for a comparative assessment of FDA approved antivirals repurposed for COVID-19 therapy identifies Trip13 as a Remdesivir off-target;2020-07-20

4. Analysis of Pharmacogenomic Variants Associated with Population Differentiation;PLOS ONE;2015-03-25

5. Induction of CYP26A1 by Metabolites of Retinoic Acid: Evidence That CYP26A1 Is an Important Enzyme in the Elimination of Active Retinoids;Molecular Pharmacology;2014-12-09